|
Tschan, M P; Reddy, V A; Ress, A et al. (2008) PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene 27:3489-93
|
|
Tschan, M P; Gullberg, U; Shan, D et al. (2008) The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias. Leukemia 22:1087-90
|
|
Tschan, Mario P; Fischer, Kimberlee M; Fung, Vivian S et al. (2003) Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J Biol Chem 278:42750-60
|
|
Manchester, Marianne; Smith, Kent A; Eto, Danelle S et al. (2002) Targeting and hematopoietic suppression of human CD34+ cells by measles virus. J Virol 76:6636-42
|
|
Buhler, B; Lin, Y C; Morris, G et al. (2001) Viral evolution in response to the broad-based retroviral protease inhibitor TL-3. J Virol 75:9502-8
|
|
Anderson, K L; Nelson, S L; Perkin, H B et al. (2001) PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45. J Biol Chem 276:7637-42
|
|
Anderson, K L; Perkin, H; Surh, C D et al. (2000) Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 164:1855-61
|
|
Crisa, L; Cirulli, V; Smith, K A et al. (1999) Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94:3928-40
|
|
Anderson, K L; Smith, K A; Perkin, H et al. (1999) PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood 94:2310-8
|
|
Miyoshi, H; Smith, K A; Mosier, D E et al. (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682-6
|
Showing the most recent 10 out of 16 publications
